The DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index.
Targeting Signal‐Transducer‐and‐Activator‐of‐Transcription‐3 for Prevention and Therapy of Cancer: Modern Target but Ancient Solution
Abstract
Recent evidence indicates a convergence of molecular targets for both prevention and therapy of cancer. Signal‐transducer‐and‐activator‐of‐transcription‐3 (STAT3), a member of a family of six different transcription factors, is closely linked with tumorigenesis. Its role in cancer is indicated by numerous avenues of evidence, including the following: STAT3 is constitutively active in tumor cells; STAT3 is activated by growth factors (e.g., EGF, TGF‐α, IL‐6, hepatocyte growth factor) and oncogenic kinases (e.g., Src); STAT3 regulates the expression of genes that mediate proliferation (e.g., c‐myc and cyclin D1), suppress apoptosis (e.g., Bcl‐x L and survivin), or promote angiogenesis (e.g, VEGF); STAT3 activation has been linked with chemoresistance and radioresistance; and chemopreventive agents have been shown to suppress STAT3 activation. Thus inhibitors of STAT3 activation have potential for both prevention and therapy of cancer. Besides small peptides and oligonucleotides, numerous small molecules have been identified as blockers of STAT3 activation, including synthetic molecules (e.g., AG 490, decoy peptides, and oligonucleotides) and plant polyphenols (e.g., curcumin, resveratrol, flavopiridol, indirubin, magnolol, piceatannol, parthenolide, EGCG, and cucurbitacin). This article discusses these aspects of STAT3 in more detail.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Waris, G., Turkson, J., Hassanein, T., & Siddiqui, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1569-1580.2005 · Cited by 157
RetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
STATs: Signal Transducers and Activators of Transcription
Ihle, J. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81277-5 · Cited by 1,381
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality
Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T., & Akira, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3801 · Cited by 1,323
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
Niu, G., Wright, K. L., Huang, M., Song, L., Haura, E., Turkson, J., Zhang, S., Wang, T., Sinibaldi, D., Coppola, D., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205260 · Cited by 1,207
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., et al. (2004) · Nature Medicine · doi:10.1038/nm976 · Cited by 1,155
Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice.
Vaisse, C., Halaas, J. L., Horvath, C. M., Darnell, J. E., Stoffel, M., & Friedman, J. M. (1996) · Nature Genetics · doi:10.1038/ng0996-95 · Cited by 1,086
Structure and function of a new STAT-induced STAT inhibitor
Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., et al. (1997) · Nature · doi:10.1038/43219 · Cited by 1,040
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
Kortylewski, M., Kujawski, M., Wang, T., Wei, S., Zhang, S., Pilon-Thomas, S., Niu, G., Kay, H., Mulé, J., Kerr, W. G., et al. (2005) · Nature Medicine · doi:10.1038/nm1325 · Cited by 1,031
Akira, S., Nishio, Y., Inoue, M., Wang, X.-J., We, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., & Kishimoto, T. (1994) · Cell · doi:10.1016/0092-8674(94)90235-6 · Cited by 1,019
Specific Inhibition of Stat3 Signal Transduction by PIAS3
Chung, C. D., Liao, J., Liu, B., Rao, X., Jay, P., Berta, P., & Shuai, K. (1997) · Science · doi:10.1126/science.278.5344.1803 · Cited by 980
Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
A Single Phosphotyrosine Residue of Stat91 Required for Gene Activation by Interferon-γ
Shuai, K., Stark, G. R., Kerr, L. M., & Darnell, J. E. (1993) · Science · doi:10.1126/science.7690989 · Cited by 802
Bromberg, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15617 · Cited by 770
Garcia, R., Bowman, T. L., Niu, G., Yu, H., Minton, S., Muro-Cacho, C. A., Cox, C. E., Falcone, R., Fairclough, R., Parsons, S., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204349 · Cited by 756
Sano, S., Chan, K. S., Carbajal, S., Clifford, J., Peavey, M., Kiguchi, K., Itami, S., Nickoloff, B. J., & DiGiovanni, J. (2005) · Nature Medicine · doi:10.1038/nm1162 · Cited by 752
Yoshikawa, H., Matsubara, K., Qian, G.-S., Jackson, P., Groopman, J. D., Manning, J. E., Harris, C. C., & Herman, J. G. (2001) · Nature Genetics · doi:10.1038/ng0501-29 · Cited by 722
Jacobson, N. G., Szabo, S. J., Weber-Nordt, R. M., Zhong, Z., Schreiber, R. D., Darnell, J. E., & Murphy, K. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1755 · Cited by 673
Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation
Turkson, J., Bowman, T., Garcia, R., Caldenhoven, E., De Groot, R. P., & Jove, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2545 · Cited by 651
Blaskovich, M. A., Sun, J., Cantor, A. B., Turkson, J., Jove, R., & Sebti, S. M. (2003) · PubMed · Cited by 643
Chung, J., Uchida, E., Grammer, T. C., & Blenis, J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6508 · Cited by 620
Stat3 Activation Is Required for Cellular Transformation by v- src
Bromberg, J. F., Horvath, C. M., Besser, D., Lathem, W. W., & Darnell, J. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2553 · Cited by 614
Radaeva, S., Sun, R., Pan, H.-N., Hong, F., & Gao, B. (2004) · Hepatology · doi:10.1002/hep.20184 · Cited by 597
Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I
Migone, T.-S., Lin, J.-X., Cereseto, A., Mulloy, J. C., O'Shea, J. J., Franchini, G., & Leonard, W. J. (1995) · Science · doi:10.1126/science.7604283 · Cited by 557
Xie, T.-X., Wei, D., Liu, M., Gao, A. C., Ali-Osman, F., Sawaya, R., & Huang, S. (2004) · Oncogene · doi:10.1038/sj.onc.1207383 · Cited by 550
Mora, L. B., Buettner, R., Seigne, J. D., Diaz, J. I., Ahmad, N., Garcia, R., Bowman, T. L., Falcone, R., Fairclough, R., Cantor, A. B., et al. (2002) · PubMed · Cited by 533
Role of chemopreventive agents in cancer therapy
Dorai, T., & Aggarwal, B. B. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.07.013 · Cited by 529
Self-citationSano, S., Itami, S., Takeda, K., Tarutani, M., Yamaguchi, Y., Miura, H., Yoshikawa, K., Akira, S., & Takeda, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4657 · Cited by 519
Bharti, A. C., Donato, N., & Aggarwal, B. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3863 · Cited by 508
Self-citationGrandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M. Y., Zeng, Q., Pitt, A. S., & Tweardy, D. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3785 · Cited by 507
Song, H., Wang, R., Wang, S., & Lin, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409894102 · Cited by 504
Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis
Bowman, T., Broome, M. A., Sinibaldi, D., Wharton, W., Pledger, W. J., Sedivy, J. M., Irby, R., Yeatman, T., Courtneidge, S. A., & Jove, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131568898 · Cited by 488
Shishodia, S., Amin, H. M., Lai, R., & Aggarwal, B. B. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.043 · Cited by 459
Self-citationTurkson, J., Ryan, D., Kim, J. S., Zhang, Y., Chen, Z., Haura, E., Laudano, A., Sebti, S., Hamilton, A. D., & Jove, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107527200 · Cited by 448
Garcia, R., Yu, C., Hudnall, A. M., Catlett, R., Nelson, K. L., Smithgall, T. E., Fujita, D. J., Ethier, S. P., & Jove, R. (1997) · PubMed · Cited by 441
Aoki, Y., Feldman, G. M., & Tosato, G. (2003) · Blood · doi:10.1182/blood-2002-07-2130 · Cited by 438
Synergistic Roles for Pim-1 and c-Myc in STAT3-Mediated Cell Cycle Progression and Antiapoptosis
Shirogane, T., Fukada, T., Muller, J. M. M., Shima, D. T., Hibi, M., & Hirano, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80145-4 · Cited by 426
STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells
Jung, J. E., Lee, H., Cho, I., Chung, D. H., Yoon, S., Yang, Y. M., Lee, J. W., Choi, S., Park, J., Ye, S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3099fje · Cited by 425
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
Zamo, A., Chiarle, R., Piva, R., Howes, J., Fan, Y., Chilosi, M., Levy, D. E., & Inghirami, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205152 · Cited by 399
Williams, L., Bradley, L., Smith, A., & Foxwell, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.567 · Cited by 393
STAT3 Is Required for the gp130-mediated Full Activation of the c-myc Gene
Kiuchi, N., Nakajima, K., Ichiba, M., Fukada, T., Narimatsu, M., Mizuno, K., Hibi, M., & Hirano, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.1.63 · Cited by 385
Masuda, M., Suzui, M., Yasumatu, R., Nakashima, T., Kuratomi, Y., Azuma, K., Tomita, K., Komiyama, S., & Weinstein, I. B. (2002) · PubMed · Cited by 376
Song, L., Turkson, J., Karras, J. G., Jove, R., & Haura, E. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206479 · Cited by 362
Alas, S., & Bonavida, B. (2001) · PubMed · Cited by 331
Wen, Z. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.11.2062 · Cited by 325
Masuda, M., Suzui, M., & Weinstein, I. B. (2001) · PubMed · Cited by 317
Weber-Nordt, R., Egen, C., Wehinger, J., Ludwig, W., Gouilleux-Gruart, V, Mertelsmann, R., & Finke, J. (1996) · Blood · doi:10.1182/blood.v88.3.809.809 · Cited by 314
Kim, H. Y., Park, E. J., Joe, E.-H., & Jou, I. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6072 · Cited by 313
O'Brien, C. A., Gubrij, I., Lin, S.-C., Saylors, R. L., & Manolagas, S. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19301 · Cited by 313
Galm, O., Yoshikawa, H., Esteller, M., Osieka, R., & Herman, J. G. (2003) · Blood · doi:10.1182/blood-2002-06-1735 · Cited by 308
Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells
Nam, S., Buettner, R., Turkson, J., Kim, D., Cheng, J. Q., Muehlbeyer, S., Hippe, F., Vatter, S., Merz, K.-H., Eisenbrand, G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409467102 · Cited by 294
Bhattacharya, S., Ray, R. M., & Johnson, L. R. (2005) · Biochemical Journal · doi:10.1042/bj20050465 · Cited by 291
Sinibaldi, D., Wharton, W., Turkson, J., Bowman, T., Pledger, W. J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203947 · Cited by 290
Natarajan, C., & Bright, J. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6506 · Cited by 288
Hao, J., Li, T.-G., Qi, X., Zhao, D.-F., & Zhao, G.-Q. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2005.11.011 · Cited by 285
Carballo, M., Conde, M., El Bekay, R., Martı́n-Nieto, J., Camacho, M. J., Monteseirı́n, J., Conde, J., Bedoya, F. J., & Sobrino, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17580 · Cited by 266
Zhang, Q., Raghunath, P. N., Xue, L., Majewski, M., Carpentieri, D. F., Odum, N., Morris, S., Skorski, T., & Wasik, M. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.466 · Cited by 262
Turkson, J., Bowman, T., Adnane, J., Zhang, Y., Djeu, J. Y., Sekharam, M., Frank, D. A., Holzman, L. B., Wu, J., Sebti, S., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7519 · Cited by 258
YU, Z., ZHANG, W., & KONE, B. C. (2002) · Biochemical Journal · doi:10.1042/bj20020588 · Cited by 255
Dechow, T. N., Pedranzini, L., Leitch, A., Leslie, K., Gerald, W. L., Linkov, I., & Bromberg, J. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404100101 · Cited by 254
Puthier, D., Bataille, R., & Amiot, M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199912)29:12<3945::aid-immu3945>3.0.co;2-o · Cited by 254
IL-21 Up-Regulates the Expression of Genes Associated with Innate Immunity and Th1 Response
Strengell, M., Sareneva, T., Foster, D., Julkunen, I., & Matikainen, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3600 · Cited by 250
Shen, Y., Devgan, G., Darnell, J. E., & Bromberg, J. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1543 · Cited by 249
Vignais, M.-L., Sadowski, H. B., Watling, D., Rogers, N. C., & Gilman, M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1759 · Cited by 248
Arnaud, C., Burger, F., Steffens, S., Veillard, N. R., Nguyen, T. H., Trono, D., & Mach, F. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000163840.63685.0c · Cited by 247
STAT3 Acts as a Co-activator of Glucocorticoid Receptor Signaling
Zhang, Z., Jones, S., Hagood, J. S., Fuentes, N. L., & Fuller, G. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30607 · Cited by 240
Frank, D. A., Mahajan, S., & Ritz, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119869 · Cited by 239
Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation
Yoshida, T., Hanada, T., Tokuhisa, T., Kosai, K.-I., Sata, M., Kohara, M., & Yoshimura, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012127 · Cited by 236
Serine Phosphorylation and Negative Regulation of Stat3 by JNK
Lim, C. P., & Cao, X. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.31055 · Cited by 225
Curcumin is a non‐competitive and selective inhibitor of phosphorylase kinase
Reddy, S., & Aggarwal, B. B. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80232-7 · Cited by 225
Self-citationNielsen, M., Kaltoft, K., Nordahl, M., Röpke, C., Geisler, C., Mustelin, T., Dobson, P., Svejgaard, A., & Ødum, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6764 · Cited by 220
GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction
Lufei, C. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg135 · Cited by 219
Mellado, M., Rodríguez-Frade, J. M., Aragay, A., del Real, G., Martín, A. M., Vila-Coro, A. J., Serrano, A., Mayor, F., & Martínez-A., C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.805 · Cited by 219
STAT3 is constitutively activated in Hodgkin cell lines
Kube, D., Holtick, U., Vockerodt, M., Ahmadi, T., Haier, B., Behrmann, I., Heinrich, P. C., Diehl, V., & Tesch, H. (2001) · Blood · doi:10.1182/blood.v98.3.762 · Cited by 218
Constitutive Activation of JAK3/STAT3 in Colon Carcinoma Tumors and Cell Lines
Lin, Q., Lai, R., Chirieac, L. R., Li, C., Thomazy, V. A., Grammatikakis, I., Rassidakis, G. Z., Zhang, W., Fujio, Y., Kunisada, K., et al. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61187-x · Cited by 207
Protein Kinase C δ Associates with and Phosphorylates Stat3 in an Interleukin-6-dependent Manner
Jain, N., Zhang, T., Kee, W. H., Li, W., & Cao, X. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24392 · Cited by 201
Fujio, Y., Kunisada, K., Hirota, H., Yamauchi-Takihara, K., & Kishimoto, T. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119484 · Cited by 200
Constitutive Activation of Stat 3 Oncogene Product in Human Ovarian Carcinoma Cells
Huang, M., Page, C., Reynolds, R. K., & Lin, J. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5931 · Cited by 189
From chemoprevention to chemotherapy: common targets and common goals
Aggarwal, B. B., Takada, Y., & Oommen, O. V. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.10.1327 · Cited by 187
Self-citationSartor, C. I., Dziubinski, M. L., Yu, C., Jove, R., & Ethier, S. P. (1997) · PubMed · Cited by 184
Demoulin, J.-B., Uyttenhove, C., Van Roost, E., Lestré, B. D., Donckers, D., Van Snick, J., & Renauld, J.-C. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4710 · Cited by 182
Epling-Burnette, P. K., Zhong, B., Bai, F., Jiang, K., Bailey, R. D., Garcia, R., Jove, R., Djeu, J. Y., Loughran, T. P., & Wei, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7486 · Cited by 181
Activation of STAT3 by the Src Family Kinase Hck Requires a Functional SH3 Domain
Schreiner, S. J., Schiavone, A. P., & Smithgall, T. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204255200 · Cited by 176
RANTES and MIP-1α Activate Stats in T Cells
Wong, M., & Fish, E. N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.309 · Cited by 175
Gurney, A. L., Wong, S. C., Henzel, W. J., & de Sauvage, F. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5292 · Cited by 171
Schaefer, L. K., Ren, Z., Fuller, G. N., & Schaefer, T. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205263 · Cited by 170
Sun, W. H., Pabon, C., Alsayed, Y., Huang, P. P., Jandeska, S., Uddin, S., Platanias, L. C., & Rosen, S. T. (1998) · Blood · doi:10.1182/blood.v91.2.570 · Cited by 169
Turkson, J., Zhang, S., Mora, L. B., Burns, A. C., Sebti, S. M., & Jove, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502694200 · Cited by 169
Wung, B., Hsu, M. C., Wu, C., & Hsieh, C. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.04.052 · Cited by 167
Stat3 and NF-κB activation prevents apoptosis in pancreatic carcinogenesis
Greten, F. R., Weber, C. K., Greten, T. F., Schneider, G., Wagner, M., Adler, G., & Schmid, R. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.37075 · Cited by 166
Horiguchi, A., Oya, M., Shimada, T., Uchida, A., Marumo, K., & Murai, M. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64741-6 · Cited by 165
Hideshima, T., Chauhan, D., Hayashi, T., Akiyama, M., Mitsiades, N., Mitsiades, C., Podar, K., Munshi, N. C., Richardson, P. G., & Anderson, K. C. (2003) · Oncogene · doi:10.1038/sj.onc.1207170 · Cited by 164
Activation of Stat3 in v-Src-transformed Fibroblasts Requires Cooperation of Jak1 Kinase Activity
Zhang, Y., Turkson, J., Carter-Su, C., Smithgall, T., Levitzki, A., Kraker, A., Krolewski, J. J., Medveczky, P., & Jove, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002383200 · Cited by 164
Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu.
Hong, R. L., Spohn, W. H., & Hung, M. (1999) · PubMed · Cited by 161
Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells
Korutla, L., & Kumar, R. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)90299-2 · Cited by 155
Banerjea, A., Ahmed, S., Hands, R. E., Huang, F., Han, X., Shaw, P. M., Feakins, R. M., Bustin, S. A., & Dorudi, S. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-21 · Cited by 154
Nunes, M., Shi, C., & Greenberger, L. M. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.21.3.1 · Cited by 148
Kordula, T., Rydel, R. E., Brigham, E. F., Horn, F., Heinrich, P. C., & Travis, J. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4112 · Cited by 141
Coleman, Ren, Z., Mandal, P. K., Cameron, A. G., Dyer, G. A., Muranjan, S., Campbell, M. L., Chen, X., & McMurray, J. S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050513m · Cited by 141
Sobota, R. M., Marcin Szwed, A., Kasza, A., Bugno, M., & Kordula, T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1948 · Cited by 138
Flowers, L. O., Subramaniam, P. S., & Johnson, H. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208437 · Cited by 137
Novak, U., Harpur, A. G., Paradiso, L., Kanagasundaram, V., Jaworowski, A., Wilks, A. F., & Hamilton, J. (1995) · Blood · doi:10.1182/blood.v86.8.2948.2948 · Cited by 136
Transcriptional Inactivation of STAT3 by PPARγ Suppresses IL-6-Responsive Multiple Myeloma Cells
Wang, L. H., Yang, X. Y., Zhang, X., Huang, J., Hou, J., Li, J., Xiong, H., Mihalic, K., Zhu, H., Xiao, W., et al. (2004) · Immunity · doi:10.1016/s1074-7613(04)00030-5 · Cited by 136
Miyazaki, T., Bub, J. D., Uzuki, M., & Iwamoto, Y. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.076 · Cited by 134
Distinct Mechanisms of STAT Phosphorylation via the Interferon-α/β Receptor
Su, L., & David, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12661 · Cited by 133
Nagel‐Wolfrum, K., Buerger, C., Wittig, I., Butz, K., Hoppe‐Seyler, F., & Groner, B. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.170.2.3 · Cited by 133
Proietti, C. J., Salatino, M., Rosemblit, C., Carnevale, R. P., Pecci, A., Kornblihtt, A. R., Molinolo, A., Frahm, I., Charreau, E. H., Schillaci, R., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.4826-4840.2005 · Cited by 130
Besser, D., Bromberg, J., Darnell, J. E., Jr., & Hanafusa, H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1401 · Cited by 129
Epigenetic inactivation of SOCS‐1 by CpG island hypermethylation in human gastric carcinoma
Oshimo, Y., Kuraoka, K., Nakayama, H., Kitadai, Y., Yoshida, K., Chayama, K., & Yasui, W. (2004) · International Journal of Cancer · doi:10.1002/ijc.20521 · Cited by 128
Stout, B. A., Bates, M. E., Liu, L. Y., Farrington, N. N., & Bertics, P. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6409 · Cited by 125
Chakravarti, N., Myers, J. N., & Aggarwal, B. B. (2006) · International Journal of Cancer · doi:10.1002/ijc.21967 · Cited by 124
Self-citationFunctional Importance of Stat3 Tetramerization in Activation of the α2-Macroglobulin Gene
Zhang, X., & Darnell, J. E., Jr. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104978200 · Cited by 124
Xia, Z., Baer, M. R., Block, A. W., Baumann, H., & Wetzler, M. (1998) · PubMed · Cited by 124
Konnikova, L., Simeone, M., Kruger, M. M., Kotecki, M., & Cochran, B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0924 · Cited by 124
Mascareno, E. J., Dhar-Mascareño, M., & Siddiqui, M. A. Q. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5590 · Cited by 122
Chen, Z., Lee, F. Y., Bhalla, K. N., & Wu, J. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020172 · Cited by 120
Activation of Stat‐3 as one of the early events in tobacco chewing‐mediated oral carcinogenesis
Nagpal, J. K., Mishra, R., & Das, B. R. (2002) · Cancer · doi:10.1002/cncr.10499 · Cited by 119
Schlessinger, K., & Levy, D. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0317 · Cited by 112
STAT3 is constitutively active in some patients with Polycythemia rubra vera
Röder, S., Steimle, C., Meinhardt, G., & Pahl, H. L. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00637-3 · Cited by 107
Activation of STAT transcription factors by herpesvirus Saimiri Tip-484 requires p56lck
Lund, T. C., Garcia, R., Medveczky, M. M., Jove, R., & Medveczky, P. G. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6677-6682.1997 · Cited by 105
Yu, C., Jove, R., & Burakoff, S. J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.11.5206 · Cited by 105
ErbB-2 Activates Stat3α in a Src- and JAK2-dependent Manner
Ren, Z. J., & Schaefer, T. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112438200 · Cited by 103
Miscia, S., Marchisio, M., Grilli, A., Valerio, V. D., Centurione, L., Sabatino, G., Garaci, F. G., Zauli, G., Bonvini, E., & Baldassarre, A. D. (2002) · PubMed · Cited by 102
To, K., Chan, M., Leung, W., Ng, E., Yu, J., Bai, A., Lo, A., Chu, S., Tong, J., Lo, K., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602133 · Cited by 101
Sato, T., Selleri, C., Young, N. S., & Maciejewski, J. P. (1997) · Blood · doi:10.1182/blood.v90.12.4749 · Cited by 101
PIAS3 Suppresses NF-κB-mediated Transcription by Interacting with the p65/RelA Subunit
Jang, H. D., Yoon, K., Shin, Y. J., Kim, J., & Lee, S. Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313018200 · Cited by 100
Hsiao, J. R., Jin, Y., Tsai, S., Shiau, A.-L., Wu, C., & Su, W. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601003 · Cited by 98
Gotoh, A., Takahira, H., Mantel, C., Litz-Jackson, S., Boswell, H. S., & Broxmeyer, H. (1996) · Blood · doi:10.1182/blood.v88.1.138.138 · Cited by 97
Tanuma, N., Nakamura, K., Shima, H., & Kikuchi, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003661200 · Cited by 95
Yang, Y., Ikezoe, T., Takeuchi, T., Adachi, Y., Ohtsuki, Y., Takeuchi, S., Koeffler, H. P., & Taguchi, H. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00063.x · Cited by 94
Chen, S., Chang, Y., Wang, D. L., & Cheng, J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706647 · Cited by 94
Independent and Cooperative Activation of Chromosomal c-fos Promoter by STAT3
Yang, E., Lerner, L. R., Besser, D., & Darnell, J. E., Jr. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213073200 · Cited by 93
bFGF and LIF signaling activates STAT3 in proliferating myoblasts
Megeney, L. A., Perry, R. L., LeCouter, J. E., & Rudnicki, M. A. (1996) · Developmental Genetics · doi:10.1002/(sici)1520-6408(1996)19:2<139::aid-dvg5>3.0.co;2-a · Cited by 93
Nielsin, M. (1997) · Proceedings of the National Academy of Sciences · Cited by 93
Jing, N., Zhu, Q., Yuan, P., Li, Y., Mao, L., & Tweardy, D. J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0302 · Cited by 91
Wu, S., Wu, X.-H., Lu, C., Dong, L., & Chen, Z. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0184oc · Cited by 90
Wang, L. H., Yang, X. Y., Mihalic, K., Xiao, W., Li, D., & Farrar, W. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105185200 · Cited by 90
Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells
Amit-Vazina, M., Shishodia, S., Harris, D., Van, Q., Wang, M., Weber, D., Alexanian, R., Talpaz, M., Aggarwal, B. B., & Estrov, Z. E. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602637 · Cited by 89
Self-citationKanai, M., Konda, Y., Nakajima, T., Izumi, Y., Kanda, N., Nanakin, A., Kubohara, Y., & Chiba, T. (2003) · Oncogene · doi:10.1038/sj.onc.1206109 · Cited by 88
Gatsios, P., Terstegen, L., Schliess, F., Häussinger, D., Kerr, I. M., Heinrich, P. C., & Graeve, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.22962 · Cited by 85
Kojima, H., Sasaki, T., Ishitani, T., Iemura, S.-I., Zhao, H., Kaneko, S., Kunimoto, H., Natsume, T., Matsumoto, K., & Nakajima, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500679102 · Cited by 81
Nagai, H., Naka, T., Terada, Y., Komazaki, T., Yabe, A., Jin, E.-J., Kawanami, O., Kishimoto, T., Konishi, N., Nakamura, M., et al. (2003) · Journal of Human Genetics · doi:10.1007/s100380300008 · Cited by 78
Chen, J., Kunos, G., & Gao, B. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01031-5 · Cited by 75
Activation of STAT3 by the c-Fes Protein-tyrosine Kinase
Nelson, K. L., Rogers, J. A., Bowman, T. L., Jove, R., & Smithgall, T. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.7072 · Cited by 75
Yoo, J.-Y., Wang, W., Desiderio, S. V., & Nathans, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009935200 · Cited by 71
Inactivation of Stat3 in tumor cells
Gamero, A. M., Young, H. A., & Wiltrout, R. H. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00028-5 · Cited by 65
Tanuma, N., Shima, H., Nakamura, K., & Kikuchi, K. (2001) · Blood · doi:10.1182/blood.v98.10.3030 · Cited by 65
Lee, Y. K., Isham, C. R., Kaufmann, S. H., & Bible, K. C. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0235 · Cited by 64
Komazaki, T., Nagai, H., Emi, M., Terada, Y., Yabe, A., Jin, E., Kawanami, O., Konishi, N., Moriyama, Y., Naka, T., et al. (2004) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyh035 · Cited by 64
Nishiki, S., Hato, F., Kamata, N., Sakamoto, E., Hasegawa, T., Eto-Kimura, A., Hino, M., & Kitagawa, S. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00387.2003 · Cited by 63
Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells
Coppo, P., Dusanter‐Fourt, I., Millot, G. A., Nogueira, M. M., Dugray, A., Bonnet, M. L., Mitjavila‐Garcia, M. T., Pesteur, D. L., Guilhot, F., Vainchenker, W., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206607 · Cited by 60
Nikitakis, N. G., Siavash, H., Hebert, C. G., Reynolds, M. A., Hamburger, A. W., & Sauk, J. J. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600618 · Cited by 59
Sellers, L. A., Feniuk, W., Humphrey, P. P. A., & Lauder, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16423 · Cited by 53
Venkatasubbarao, K., Choudary, A., & Freeman, J. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2396 · Cited by 53
Hepatitis C virus NS5A mediated STAT3 activation requires co-operation of Jak1 kinase
Sarcar, B., Ghosh, A. K., Steele, R., RAY, R. K., & Ray, R. B. (2004) · Virology · doi:10.1016/j.virol.2004.01.008 · Cited by 52
Carl, V. S., Gautam, J., Comeau, L., & Smith, M. F. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1003526 · Cited by 52
STAT3 is activated in a subset of the Ewing sarcoma family of tumours
Lai, R. L., Navid, F., Galindo, C. R., Liu, T., Fuller, C., Ganti, R., Dien, J., Dalton, J., Billups, C. A., & Khoury, J. (2006) · The Journal of Pathology · doi:10.1002/path.1941 · Cited by 47
Ahsan, H., Aziz, M. H., & Ahmad, N. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.106 · Cited by 31
Suppression of STAT3 Activity by Duplin, Which Is a Negative Regulator of the Wnt Signal
Yamashina, K., Yamamoto, H., Chayama, K., Nakajima, K., & Kikuchi, A. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj033 · Cited by 29
Bhonde, M., Hanski, M., Magrini, R., Moorthy, N. D., Müller, A., Sausville, E. A., Kohno, K., Wiegand, P., Daniel, P. T., Zeitz, M., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207842 · Cited by 28
Constitutive Activation of Stat1 and Stat3 in Primary Erythroleukemia Cells
Kirito, K., Nagashima, T., Ozawa, K., & Komatsu, N. (2002) · International Journal of Hematology · doi:10.1007/bf02981979 · Cited by 28
Faderl, S. H., Ferrajoli, A., Harris, D., Van, Q., Priebe, W., & Estrov, Z. E. (2005) · PubMed · Cited by 27
15-Deoxy-Δ12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes
Kim, H. J., Rho, Y. H., Choi, S. J., Lee, Y. H., Cheon, H. J., Um, J. W., Sohn, J., Song, G. G., & Ji, J. D. (2005) · Experimental & Molecular Medicine · doi:10.1038/emm.2005.24 · Cited by 20
Bhat, G. J., Hunt, R. A., & Baker, K. M. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0520 · Cited by 11
(1998) · doi:10.1002/(sici)1097-0215(19981029)78:3<326::aid-ijc12>3.0.co;2-4
Cited by
Curcumin: From ancient medicine to current clinical trials
Hatcher, H., Planalp, R., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,843
Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
Dhillon, N., Aggarwal, B. B., Newman, R. A., Wolff, R. A., Kunnumakkara, A. B., Abbruzzese, J. L., Ng, C. S., Badmaev, V., & Kurzrock, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0024 · Cited by 1,331
Self-citationMolecular inflammation: Underpinnings of aging and age-related diseases
Chung, H. Y., Cesari, M., Anton, S., Marzetti, E., Giovannini, S., Seo, A. Y., Carter, C., Yu, B. P., & Leeuwenburgh, C. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2008.07.002 · Cited by 1,203
Role of Pro-Inflammatory Cytokines Released from Microglia in Neurodegenerative Diseases
Smith, J. A., Das, A., Ray, S. K., & Banik, N. L. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.10.004 · Cited by 1,165
Aggarwal, B. B., & Sung, B. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.11.002 · Cited by 1,140
Self-citation
Metadata
- Authors
- AGGARWAL, B. B., SETHI, G., AHN, K. S., SANDUR, S. K., PANDEY, M. K., KUNNUMAKKARA, A. B., SUNG, B., & ICHIKAWA, H.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2006-12
- Volume
- 1091
- Issue
- 1
- Pages
- 151-169
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2102153675
- Cited by
- 398
- References
- 170
- FWCI
- 10.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.